The size of the European Atrial Fibrillation Surgery Market is predicted to worth USD 0.40 Billion in 2022. It is expected to grow at a CAGR of 13.1% to reach USD 0.73 million by 2027. The U.K leads the market due to the growing occurrences of atrial fibrillation and increasing health awareness.
A growing number of patients affected with atrial fibrillation in the European countries, acceptable regulations supporting the increasing utilization of catheter, and surgical ablation treatments of atrial fibrillation are the factors escalating the atrial fibrillation surgery market of Europe. The regularity of atrial fibrillation and less treatment cost support the mounting are leveling the market demand. Around 10 million people in Europe live with atrial fibrillation, published by the European Heart Network journal. Factors like developed healthcare infrastructure and accessibility of skilled labor are boosting up the demand of the market. A regular increase in obesity is propelling the growth rate of the atrial fibrillation surgery market. An increase in healthcare expenditure and growing disposable income is likely to add fuel to the region's market growth. Moreover, the minimized death rate and positive results of atrial fibrillation devices are estimated to mount the market growth in the area over the period.
Lack of awareness regarding the surgeries associated with atrial fibrillation and accessibility of few pharmaceutical replacements are likely to hinder the market. However, the cost of the treatment procedure is impeding the market demand. Lack of experienced professionals needed at the time of treatment of performing surgery is acting as an excellent barrier for the growth of the atrial fibrillation market in Europe.
This research report on the Europe Atrial Fibrillation Surgery Market has been segmented and sub-segmented into the following categories:
The European market was positioned as second largest in 2019 in the global atrial fibrillation surgery market and predicted to continue growing throughout the forecast period. The growth of the region is attributed due to reimbursement schemes, and the rise in prominence for surgeries is fueling the market growth throughout the period.
The United Kingdom is anticipated to lead the European market during the forecast period. Stimulating the occurrence of atrial fibrillation and growth in healthcare awareness are propelling the market in the region. Available funds for research programs being organized by the government and other private organizations are accelerating the market growth throughout the period. Moreover, factors like anxiety, stress, and lifestyle changes and augmenting the number of heart patients are likely to drive the market further. Germany is expected to witness notable growth in the region due to increasing patient count and adopting sedentary lifestyles.
Key Market Companies leading the Europe Atrial Fibrillation Surgery Market profiled in the Report are Biosense Webster, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Medtronic, Inc., Cardima, Inc. Cardiofocus, Inc., nContact, Inc., and Biotronik SE & Co.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Surgical Procedure
5.1.2 Catheter Ablation Procedures
5.1.3 Surgical Ablation/Maze Procedures
5.1.4 Y-o-Y Growth Analysis, By Surgical Procedure
5.1.5 Market Attractiveness Analysis, By Surgical Procedure
5.1.6 Market Share Analysis, By Surgical Procedure
5.2.2 Catheter Ablation Device
5.2.3 Surgical Ablation Device
5.2.4 Y-o-Y Growth Analysis, By Product
5.2.5 Market Attractiveness Analysis, By Product
5.2.6 Market Share Analysis, By Product
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Surgical Procedure
184.108.40.206 By Product
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Surgical Procedure
22.214.171.124 By Product
6.1.5 Market Share Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Surgical Procedure
184.108.40.206 By Product
6.7 Rest of Europe
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic, Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biosense Webster, Inc.
8.3 Boston Scientific CorporationInternational
8.4 St. Jude Medical, Inc.
8.5 Cardiofocus, Inc.
8.6 Atricure, Inc.
8.7 Carima, Inc.
8.8 Ncontact, Inc.
8.9 Biotroik Se & Co.Kg
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.